Purchase Order 75F40123P00200
Award Date 8/17/23
Potential Completion Date 9/2/24
Potential Value $127K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bohemia, NY 11716, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $181,170.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the provision of Sartorius bioreactor units and accessories. This contract does not have a set-aside designation. Sartorius Stedim North America Inc. is a critical supplier to various federal agencies, providing advanced laboratory equipment, consumables, and...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed-price purchase order valued at $211,279.00 to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of the AMBR250 4-WAY MODULAR SYSTEM, which is a bioreactor product used to support the biopharmaceutical manufacturing process. Sartorius Stedim North America Inc. is a leading provider of laboratory equipment, consumables,...
- The Department of Health and Human Services Food and Drug Administration awarded a $227,968.50 firm fixed price purchase order for service and maintenance on a Sartorius Stedim North America Inc. Ambr 15 bioreactor system. The contract has a completion date of June 30, 2023 and was awarded on a competitive basis with no set-aside designation. Sartorius Stedim North America Inc. is the prime contractor, a division of the German company Sartorius Aktiengesellschaft, and has fulfilled over $2...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, to provide an AMBR15 analysis module equipped with BioPAT Spectro hardware and flow cell. The contract has a potential value of $90,507.50 and a completion date of November 17, 2023. No set-aside designation was used for this award. Sartorius Stedim North America Inc. is a...
- This is a $210,267.91 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft. The contract is for the delivery of off-line gas analyzers, on-line and integral nutrient analyzers, bioreactor probes, and accessories for a Sartorius BIOSTAT bioreactor system. This award does not have a set-aside designation. Sartorius Stedim North America...
- Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, has been awarded a $46,330.00 firm fixed price purchase order contract by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center. The contract, which does not have a set-aside designation, is for the delivery of various laboratory equipment and consumables, including bioreactors, filtration systems, and analytical testing products, to support the...
- Sartorius Stedim North America Inc. was awarded a $247,427.86 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for the delivery of various Sartorius biological consumables and laboratory equipment in support of the Vaccine Research Center's Vaccine Production Program Laboratory. Key items to be provided include Sartocon Slice Hydrosart filters of various...
- The Food and Drug Administration (FDA) awarded a $23,697 firm fixed-price purchase order to Sartorius Stedim North America Inc. for hollow fiber filtration units on August 4, 2022, with an ultimate completion date of August 14, 2023. The contract, identified as CDER-2022-112985-DM, was awarded without a small business set-aside designation. Sartorius Stedim North America, a subsidiary of German multinational Sartorius Aktiengesellschaft and a registered federal contractor since 2008, serves as...
- Sartorius Stedim North America Inc. was awarded a $326,622.90 firm fixed-price purchase order by the U.S. Department of Agriculture's Agricultural Research Services to supply and install a Biostat B bioreactor dual control unit at the National Center for Agricultural Utilization Research (NCAUR) in Bohemia, New York. The contract, awarded on September 6, 2024, with completion by January 4, 2025, fulfills the government's requirement for a dual control unit compatible with existing B. Braun...
- Sartorius Stedim North America Inc. has been awarded a firm fixed-price purchase order valued at $182,615.50 for the installation and training of large-scale bioreactors. The contract, awarded on August 1, 2024, supports the biodefense medical (BDM) initiative's requirement for large-scale bioreactor systems essential for efficiently producing biologics at commercial scale. Performance will be completed in Manhattan, Kansas, with a deadline of September 30, 2025. This is a civilian contract...